Inno A, Bogina G, Settanni G, Salgarello M, Foti G, Pomari C, Picece V, Gori S. First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. dti [Internet]. 2023 Oct. 6 [cited 2024 Nov. 23];17(1):110-3. Available from: https://journals.aboutscience.eu/index.php/dti/article/view/2626